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Summary
QUESTION: Is there an association between the presence
of nucleated red blood cells (NRBCs) in the peripheral
blood and outcomes in critically ill children?
METHODS: Prospective observational study conducted in
2008 (January to December) in a multidisciplinary paediat-
ric intensive care unit (PICU) of a tertiary children’s hospit-
al. We provide univariate analysis, stratified by age group
(neonates and children >28 days of age), and multiple lo-
gistic regression, comparing clinically important outcomes
(death, ventilation, renal replacement therapy, inotropic
support) with haematological (NRBC, haemoglobin, plate-
lets, leucocytes), illness severity (expected mortality [pae-
diatric index of mortality, PIM2]), demographic (age, sex)
and diagnostic parameters and length of stay. Haematolo-
gical parameters correspond to the first 24 hours of PICU
admission.
RESULTS: Out of 670 patients, 195 (29.1%) were NRBC
positive and 475 (70.9%) were NRBC negative. In the
neonatal age group (n = 232), patients who died, were
ventilated or received inotropic support had significantly
more NRBCs than patients without these conditions (p
= 0.032, 0.038 and 0.029, respectively). In the child age
group (n = 438), only renal replacement therapy was signi-
ficantly associated with NRBC (p <0.001). High PIM score
(p <0.001) and longer length of stay (p <0.001) were in-
dependently associated with bad outcomes (composite end-
point: mortality and/or ventilation and/or renal replacement
therapy and/or inotropic support); NRBC positivity was not
an independent predictor of bad outcome (odds ratio 1.44,
95% confidence interval 0.62‒3.41).
CONCLUSIONS: NRBCs are not an independent risk
factor for bad outcomes in paediatric intensive care.
However, NRBCs may have some prognostic value in the
first month of life. In children >1 month of age, the as-
sociation between NRBC and outcome is much less pro-
nounced.
Trial registration number: StV-01/08
Key words: nucleated red blood cells; illness severity
score; mortality; children
Introduction
Nucleated red blood cells (NRBCs) are a normal finding in
the peripheral blood of the foetus and neonate. The more
premature an infant, the higher the NRBC count at birth [1,
2]. The normal NRBC count in the term infant is around
0.1–0.2x109/l (0.1–0.2 G/l). Beyond the neonatal period,
NRBCs are no longer detectable in the peripheral blood [1,
2]. In neonates, the NRBC count correlates with the sever-
ity of chronic prepartum and acute intrapartum states of im-
paired oxygen transport [1–5]. In healthy infants, children
and adults NRBCs are not present in the peripheral blood
[6]. In critically ill adult patients, the presence of NRBCs
is a strong predictor of mortality [6, 7]. In these patients,
NRBCs may be considered as a parameter that sums hyp-
oxic and inflammatory injuries [6]. It has been shown in
children and in adults that there is an association between
NRBCs and length of cardiopulmonary bypass [8, 9], and
NRBCs have been found shortly after cardiopulmonary ar-
rest in children [10]. There is no study on the prognost-
ic value of NRBC in the paediatric population beyond the
neonatal period.
We undertook this study to investigate if there is an associ-
ation between the appearance of NRBCs in the peripheral
blood smear of critically ill paediatric patients and bad out-
comes.
Methods
Design and setting
This prospective observational study was performed in the
multidisciplinary 18 bed tertiary neonatal-paediatric intens-
ive care unit (PICU) at the University Children’s Hospital
in Zurich, from January to December 2008. There are about
1,000 admissions a year. In the neonatal age group the unit
admits mainly term, outborn infants with cardiac or surgic-
al problems.
Ethical approval to conduct this study was granted by the
Ethical Committee of Canton Zurich (reference number:
StV-01/08).
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Patients’ characteristics
We included all patients admitted to PICU and excluded
patients who were admitted for the second time. In the
neonatal age group, 24% of infants were premature (<36
6/7 weeks of gestation) at PICU admission.
Laboratory measurements
Blood samples for measurement of absolute counts of
NRBCs, leucocytes and platelets, as well as haemoglobin
concentration, were taken during the first 24 hours of PICU
admission. We took the first results performed (not the
worst or a second one). Blood counts were measured using
a Sysmex XE-2100 blood analyser (Sysmex, Horgen,
Switzerland). NRBCs were expressed as an absolute num-
ber per litre and not per 100 white blood cells because
of the risk of confounding effects related to the leucocyte
count. Processes that increase the leucocyte count will res-
ult in a misleadingly low value of NRBCs when reported
relative to the white blood cell count, and processes that
decrease leucocyte count will produce misleadingly high
NRBC counts [11]. NRBC positivity was defined as an ab-
solute count >0. There was a special arrangement to meas-
ure the absolute count of NRBCs during the period of data
collection, because NRBC counts had not been routinely
performed before this study.
Demographic, diagnostic, illness severity and outcome
parameters
Demographic, diagnostic, severity of illness and outcome
parameters referred to the entire stay in PICU.
Demographic parameters: age and sex.
Diagnostic variables: diagnosis was coded according to
the ANZPIC registry [12]. We referred to the main dia-
gnosis; each patient had only one diagnosis. Some dia-
gnoses were represented by a very low number of patients
so we collapsed the diagnoses to three groups as follows:
postprocedural, cardiac surgery open and cardiovascular;
gastrointestinal, renal and respiratory; neurological, injury
and miscellaneous. We analysed the diagnostic subgroup
“post open cardiac surgery” separately and therefore ex-
cluded it from the “postprocedural” diagnostic group.
Severity of illness variable: expected PICU mortality
(PIM2: Paediatric Index of Mortality [13]). Length of stay
(LOS) in PICU was regarded as a separate patient charac-
teristic.
Outcome parameters: observed PICU mortality, mechanic-
al ventilation (invasive as well as noninvasive ventilation
/ continuous positive airway pressure [CPAP]), renal re-
placement therapy and use of inotropic support (none, one,
or multiple drugs).
All these parameters were drawn from the electronic data-
set of the PICU.
Statistics
The aim of this study was to investigate whether there is
an association between the presence and/or the number of
NRBCs in the peripheral blood and outcomes in critically
ill children. In addition to NRBCs, other possible explan-
atory variables for outcomes were analysed, such as demo-
graphic, diagnostic, illness severity and other haematolo-
gical parameters.
We compared the NRBC-positive with the NRBC-negative
patient group regarding the above mentioned haematolo-
gical, demographic, diagnostic, illness severity and out-
come parameters. Because NRBCs are a normal finding
in neonates, we formed two age subgroups: neonates (≤28
days of age) and children (>28 days of age). We were also
interested in the specific NRBC count of patients who un-
derwent open cardiac surgery and therefore analysed this
subgroup separately.
To associate a nominal variable to another nominal vari-
able, we provided a frequency table as well as a p-value of
either a chi-square or Fisher's exact test, whichever was ap-
propriate. Since most of the continuous variables we were
looking at were not normally distributed, we used the Wil-
coxon test to compare a continuous variable between two
groups.
Composite endpoint: given the rarity of each of the out-
come events (death in PICU, ventilation, renal replacement
therapy and inotropic support), a composite event was cre-
ated to capture “bad outcomes” in the PICU, and was used
to overcome concerns of sparsity in the multivariate mod-
elling. The composite endpoint took the value yes if at least
one of the four outcome variables was assigned with a yes.
We compared haematological, demographic and severity of
illness parameters between groups built by mortality yes/
no, ventilation yes/no, renal replacement therapy yes/no
and inotropic support yes/no. Because age is an important
stratification [2, 11], we analysed the data separately for
neonates and children.
Multiple logistic regression for the composite endpoint was
performed to find independently associated risk factors for
bad outcome. There were 425 patients with a “yes” and 245
patients with a “no” for the composite endpoint. Independ-
ent variables were NRBC positivity, age (newborn), dia-
gnosis (gastrointestinal/renal/respiratory and neurological/
injury/miscellaneous, respectively), sex (male), the
haematological values (haemoglobin, platelets and leuco-
cyte count), PIM2 and LOS.
All p-values ≤0.05 were considered statistically significant.
Computations were done with R (R Development Core
Team, 2010) [14].
Results
1,079 patients were admitted to our PICU during the study
period. Measurement of blood parameters for 7 days after
PICU admission was foreseen. Median length of stay in
PICU was 3.5 days for the NRBC-positive and 1.7 days for
Figure 1
Inclusion and exclusion criteria.
NRBC = nucleated red blood cell; PICU = paediatric intensive care
unit
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the NRBC-negative patient group. This means that many
patients had only a short PICU stay. In order to include as
many patients as possible, we thus limited the analysis of
blood parameters to the first 24 hours of PICU admission.
Unfortunately, NRBCs were not always evaluated, espe-
cially during the first months of the study and in the end we
had to exclude 409 patients (missing blood counts and mul-
tiple admissions). After excluding these patients, we could
perform the study with 670 patients (fig. 1).
We found 195 (29.1%) NRBC-positive and 475 (70.9%)
NRBC-negative patients with 171 NRBC-positive patients
(73.7%) in the neonatal age group (n = 232) and 24 NRBC-
positive patients (5.5%) in the child age group (n = 438).
Standardised mortality ratio for all patients was 0.58 (SMR
= observed mortality divided by expected mortality; ob-
served mortality: 19/670 = 2.8%, expected mortality (mean
PIM2 score of all patients): 4.9%).
Demographic, outcome and haematological parameters for
the NRBC-positive and NRBC-negative patients are shown
in table 1. PICU mortality was significantly higher in
NRBC positive patients (p <0.001). These patients were
younger (p <0.001), more often ventilated (p <0.001) and
needed more inotropic support with one or multiple drugs
(p <0.001 and p = 0.002, respectively). In addition, they
suffered mostly from respiratory problems (p <0.001), had
a significantly higher PIM2 score (p <0.001) and a longer
length of stay in the PICU (p <0.001).
Comparison between outcome variables and haematologic-
al, demographic, severity of illness parameters and LOS
stratified by age subgroup can be found in table 2. In the
neonatal age group, patients who died, were ventilated or
received inotropic support had significantly more NRBCs
in their blood than patients without these conditions, and
there was a significant association between NRBC pos-
itivity, inotropic support and the composite endpoint. In
children >1 month of age there were scarcely any NRBC-
positive patients. The only significant association between
NRBCs and outcome was found for renal replacement ther-
apy. There was no significant association between outcome
events and the other haematological parameters in
neonates, whereas some of the (bad) outcome events cor-
relate significantly with lower platelet and lower leucocyte
counts in the child age group (table 2b). In most cases,
severity of illness parameter (PIM2) and LOS correlated
significantly with outcome parameters in both age groups.
Results of multiple logistic regression are displayed in
table 3. The odds for a NRBC-positive patient to have a
yes for the composite endpoint was increased by a factor
of 1.4 (95% confidence interval 0.62‒3.41) compared with
a NRBC-negative patient adjusted for all the other vari-
ables in the model. However, this association was not signi-
ficant (p = 0.40). The variables that independently explain
the composite endpoint are diagnosis, expected mortality
(PIM2) and LOS.
Table 1: Demographic, diagnostic, severity of illness and outcome data (outcome data referring to the entire stay at PICU) and haematological parameters (on the first day
of admission) in NRBC-positive and NRBC-negative patients. For nominal variables, we provide absolute (n) and relative (%) frequency. For continuous variables, we
provide median and interquartile range.
NRBC positive (n = 195) NRBC negative (n = 475) p-value
Nominal variables n % n %
Age group 171 neonates
24 children1
87.7
12.3
61 neonates
414 children2
12.8
87.2
<0.001
PICU mortality 13 patients 6.7 6 patients 1.3 <0.001
Ventilation (invasive and noninvasive) 136 69.7 247 52.0 <0.001
Renal replacement therapy 10 5.1 17 3.6 0.39
Inotropic support
– one drug
– multiple drugs
104
49
55
53.3
25.1
28.2
143
62
81
30.1
13.1
17.0
<0.001
<0.001
0.002
ANZPIC diagnosis 72 respiratory
38 cardiovascular
22 miscellaneous
17 postprocedural
16 neurological
10 gastrointestinal
9 open card. s.
8 renal
3 injury
36.9
19.5
11.3
8.7
8.2
5.1
4.6
4.1
1.5
53 respiratory
19 cardiovascular
42 miscellaneous
150 postprocedural
40 neurological
9 gastrointestinal
104 open card. s.
8 renal
50 injury
11.2
4.0
8.8
31.6
8.4
1.9
21.9
1.7
10.5
<0.001
Sex 80 female
115 male
41.1
58.9
183 female
292 male
38.5
61.5
0.60
Continuous variables Median IQR Median IQR
NRBC (G/l) 0.28 0.62 0 0 <0.001
Haemoglobin (g/l) 159.5 55.25 114.0 33.0 <0.001
Platelets (G/l) 211 112 221 176 0.14
Leucocytes (G/l) 14.9 9.75 10.1 6.1 <0.001
PIM2 (%) 5.49 8.9 1.51 1.64 <0.001
Length of stay (days) 3.5 5.13 1.69 2.25 <0.001
Mean (95% CI) Mean (95% CI)
Standardised mortality ratio 0.7 (0.41‒1.21) 0.42 (0.19‒0.94)
ANZPIC = Australian and New Zealand Paediatric Intensive Care Society; CI = confidence interval; IQR = interquartile range; NRBC = nucleated red blood cell; Open card.
s. = open cardiac surgery; PICU = paediatric intensive care unit; PIM = paediatric index of mortality
1 median age: 0.81 years (range 13.2); 2 median age: 3.57 years (range 24.8)
Neonates: ≤28 days of age; children: >28 days of age.
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In the subgroup of post open cardiac surgery, there were 9
NRBC-positive patients and 104 NRBC-negative patients.
Seven of the nine NRBC-positive patients were in the
neonatal age group.
There were 381 patients excluded because of missing
NRBC determination in the first 24 hours. This group was
composed as follows: 18.6% neonates (<1 month of age).
The three most frequent diagnoses were “respiratory” (n =
67, 17.6%), “injury” (n = 54, 14.2%) and “miscellaneous”
(n = 34, 8.9%), respectively. Mortality was 1.6% (6 patients
died), 103 patients (27%) were ventilated. LOS was 0.86
days (median) and PIM2 score was 2.83% (mean). In the
study sample (n = 670), the respective percentages were:
neonates 34.6%, “respiratory” 18.6%, “injury” 7.9%, “mis-
cellaneous” 9.6%, mortality 2.8%, ventilation 57.2%. Me-
dian LOS was 1.92 days and mean PIM2 was 4.9%.
Discussion
NRBCs may have a prognostic significance in the first
month of life. In neonates, most of the bad outcome para-
meters correlated with the absolute number of NRBCs and/
or NRBC positivity (table 2a). In older children, we found
a correlation only for renal replacement therapy but the
small percentage of NRBC-positive patients in the child
age group (5.5%) precludes reliable statistical results for
children older than 28 days. Critically ill neonates may be
more prone to NRBC production/release than critically ill
Table 2: Univariate analysis based upon clinically important outcomes compared with demographic and haematological variables as well as severity of illness parameters.
For nominal variables, relative frequencies are shown; for continuous variables, median is displayed. Composite endpoint: death and/or ventilation and/or renal
replacement therapy and/or inotropic support. All p-values <0.05 are in bold type.
Table 2a: Neonates (≤28 days of age; n = 232).
Outcome parameters NRBC
(G/l)
NRBC
positive
(%)
Hb
(g/l)
Platelets
(G/l)
Leucocytes
(G/l)
Sex male
(%)
PIM2
(%)
LOS
(days)
Mortality
D (n = 15)
A (n = 217)
p-value
0.50
0.18
0.032
86.7
72.8
0.36
159.0
159.0
0.92
179.0
225.0
0.066
19.6
13.4
0.38
33.3
63.1
0.04
22.26
2.96
<0.001
6.05
3.36
0.11
Ventilation
Y (n = 161)
N (n = 71)
p-value
0.21
0.15
0.038
77.6
64.8
0.06
157.0
166.0
0.19
223.0
239.0
0.16
14.2
12.7
0.43
59.6
64.8
0.55
7.56
1.62
<0.001
4.76
1.29
<0.001
Renal replacement therapy
Y (n = 7)
N (n = 225)
p-value
0.17
0.19
0.57
71.4
73.8
1.00
161.0
158.5
0.48
176.5
224.0
0.54
8.7
13.5
0.17
57.1
61.3
1.00
5.60
3.77
0.43
6.72
3.36
0.14
Inotropic support
Y (n = 117)
N (n = 115)
p-value
0.21
0.16
0.029
83.8
63.5
<0.001
157.0
161.0
0.54
215.0
239.0
0.078
13.7
13.4
0.39
59.0
63.5
0.57
7.96
2.25
<0.001
5.60
2.07
<0.001
Composite endpoint
Y (n = 175)
N (n = 57)
p-value
0.21
0.12
0.056
77.7
61.4
0.02
157.0
166.0
0.49
222.5
246.0
0.15
14.2
12.2
0.25
60.0
63.2
0.85
6.84
1.72
<0.001
4.66
1.19
<0.001
A = alive; D = dead; Hb = haemoglobin; LOS = length of stay; N = no; NRBC = nucleated red blood cells; PIM = paediatric index of mortality; Y = yes
Table 2b: Children (>28 days of age; n = 438).
Outcome parameters NRBC
(G/l)
NRBC
positive
(%)
Hb
(g/l)
Platelets
(G/l)
Leucocytes
(G/l)
Sex male
(%)
PIM2
(%)
LOS
(days)
Mortality
D (n = 4)
A (n = 434)
p-value
0
0
0.63
0
5.5
1.0
103.0
111.0
0.66
197.0
215.0
0.74
10.9
10.1
0.55
75.0
60.4
1.00
31.62
1.44
0.002
15.27
1.59
0.93
Ventilation
Y (n = 222)
N (n = 216)
p-value
0
0
0.63
5.0
6.0
0.78
111.0
110.5
0.11
181.0
248.0
<0.001
9.3
10.95
0.004
61.3
59.7
0.82
1.94
1.02
<0.001
2.10
0.84
<0.001
Renal replacement therapy
Y (n = 20)
N (n = 418)
p-value
0
0
< 0.001
25.0
4.5
0.003
116.0
111.0
0.94
137.0
218.0
0.012
10.65
10.10
0.79
45.0
61.2
0.22
2.82
1.44
0.038
6.96
1.56
<0.001
Inotropic support
Y (n = 130)
N (n = 308)
p-value
0
0
0.58
4.6
5.8
0.77
117.5
109.0
<0.001
142.5
223.0
<0.001
8.90
10.50
0.007
60.0
60.7
0.97
2.03
1.22
<0.001
2.88
0.94
<0.001
Composite endpoint
Y (n = 250)
N (n = 188)
p-value
0
0
0.34
6.4
4.3
0.44
110.0
111.0
0.71
182.0
249.0
<0.001
9.40
11.05
<0.001
60.0
61.2
0.88
1.88
0.98
<0.001
2.01
0.80
<0.001
A = alive; D = dead; Hb = haemoglobin; LOS = length of stay; N = no; NRBC = nucleated red blood cells; PIM = paediatric index of mortality; Y = yes
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children. A possible explanation might be a difference in
interleukin-6, erythropoietin (EPO) or catecholamine pro-
duction between these two age groups. Additionally,
younger children have a lower threshold for NRBC release
into the circulation than older children or adults [8].
NRBCs may be considered as a parameter that sums hyp-
oxic and inflammatory injuries [6]. Interleukin-6 is a me-
diator of the EPO upregulation in children with systemic
inflammatory response syndrome triggered by septic shock
[15]. A former study showed that there is a significant and
positive correlation between EPO levels and NRBC counts
[16]. Suppression of EPO by red blood cell transfusion has
been shown to decrease NRBC counts significantly [17].
Catecholamines may also play a role in increasing NRBC
count. In animal experiments, catecholamines have been
shown to increase EPO production [18, 19]. Therefore,
the significant association between inotropic support and
NRBC in neonates may be due to critical illness (needing
inotropes) or may be a direct consequence of the drug.
A possible explanation for the only significant correlation
of NRBCs with renal replacement therapy in the older age
group (>28 days of age) might be the very critical state of
these patients. In our unit, renal replacement therapy is usu-
ally done in patients with a history of several days of crit-
ical illness, evolving towards multiple organ failure. This
may be a trigger strong enough for NRBC release with a
trigger threshold probably higher than in the neonatal peri-
od. Interestingly, bad outcome parameters were associated
with low platelet counts and low leucocyte counts in the
child age group. In our study, these haematological para-
meters were more sensitive markers of bad outcome than
NRBCs.
In both age groups, there was a good association between
the outcome events we chose for this study and the severity
of illness parameter (PIM2) as well as LOS (table 2). This
is at least an indication that the outcome parameters may in
fact describe bad outcomes.
Parameters which independently explained bad outcomes
in multiple logistic regression were diagnosis, severity of
illness and LOS. There was no significant independent pro-
gnostic role of NRBC positivity (odds ratio 1.44, 95%
confidence interval 0.62–3.41). However, NRBC positivity
might show a trend as an independent predictor of bad out-
comes.
A recently published study in adults admitted to a surgical
intensive care unit [20] found that any positive NRBC
value was associated with a poor outcome and that increas-
ing NRBC values were associated with an increasing mor-
tality. Additionally, there were trends in NRBC values and
a return to zero was protective in comparison with values
that never returned to baseline. Our study was not designed
to detect any trend of NRBC values, but results in this field
are very interesting and further investigation in the paediat-
ric population is needed.
We could not reproduce the finding that patients after open
cardiac surgery with cardiopulmonary bypass have more
NRBCs in their peripheral blood smear [8]. This may be
explained by the duration of the observation period; Frey et
al. [8] took the NRBC count for the first to the tenth post-
operative day, showing higher peak levels in the later post-
operative course; we analysed only the first 24 hours after
PICU admission.
We had to exclude 381 patients because of missing NRBC
determination in the first 24 hours of PICU admission and
are well aware of a possible bias. The excluded patients
had lower illness severity than the analysed patients (lower
PIM2 score, lower LOS and lower proportion of ventilated
patients). The relatively good condition of these patients
may explain why no blood film was taken at admission.
Secondly, for statistical reasons, diagnostic groups had to
be arbitrarily collapsed for multiple logistic regression cal-
culations. Therefore, we are not able to say which specific
diagnoses are independently associated with NRBCs.
Thirdly, mortality is typically low in paediatric intensive
care, which makes it more difficult to find an association
between NRBC and bad outcomes, compared with adult
intensive care. The composite endpoint in our study was
dominated by the more frequent outcomes “ventilation”
and “inotropic support”.
Conclusion
The association of NRBCs in the first 24 hours after ad-
mission and outcomes of critically ill children is age de-
Table 3: Multiple logistic regression for the composite endpoint (dependent variable). The composite endpoint (death and/or ventilation and/or renal replacement therapy
and/or inotropic support) had a value yes if at least one of the four outcome variables mortality, ventilation, renal replacement therapy or inotropic support was assigned
with a yes. Interpretation for “newborn yes” (binary variable): the odds for a “yes" for the composite endpoint are decreased by a factor of exp(–0.47) = 0.627 for patients
with a newborn status of “yes" compared to those with a “no" for newborn. Interpretation for “haemoglobin (g/l)” (continuous variable): the odds for having a “yes" for the
composite endpoint are decreased by a factor of exp(–0.002) = 0.998 for an increase of haemoglobin by one unit. This effect is multiplicative, i.e., for a value of
haemoglobin that is by a factor of 2 higher, the odds for a “yes" are decreased by a factor of exp(2*-0.002) = 0.997. Interpretation for “log(PIM2)”: an increase of log(PIM2)
by 1% increases the odds for having a “yes" for the composite endpoint by a factor of exp(1.333) = 3.794.
Estimate Odds ratio p-value 95% confidence interval for
odds ratio
NRBC positive 0.37 1.44 0.40 (0.62‒3.41)
Newborn yes –0.47 0.63 0.33 (0.24‒1.59)
Diagnosis gastrointestinal/renal/respiratory –2.51 0.08 <0.001 (0.04‒0.16)
Diagnosis neurological/injury/miscellaneous –3.03 0.05 <0.001 (0.02‒0.09)
Sex male –0.13 0.88 0.61 (0.54‒1.44)
Haemoglobin (g/l), per one unit increase –0.002 1.00 0.74 (0.99‒1.01)
Platelets (G/l), per one unit increase –0.002 1.00 0.42 (1.00‒1.00)
log (Leucocytes [G/l]), per one unit increase –0.23 0.79 0.31 (0.50‒1.23)
log (PIM2 [%]), per one unit increase 1.33 3.79 <0.001 (2.87‒5.12)
log (LOS [days]), per one unit increase 1.37 3.94 <0.001 (2.90‒5.47)
LOS = length of stay; NRBC = nucleated red blood cell; PIM = paediatric index of mortality
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pendent. In the first month of life of mainly term infants,
increased numbers of NRBCs had a prognostic value in re-
gard to mortality, ventilation and inotropic support. In chil-
dren >1 month of age, the association between NRBCs and
outcome is much less pronounced. However, PIM2 score,
LOS and diagnosis independently predicted bad outcome
(death and/or ventilation and/or renal replacement therapy
and/or inotropic support). Further investigations are needed
to assess trends in NRBC values for critically ill children.
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Figures (large format)
Figure 1
Inclusion and exclusion criteria.
NRBC = nucleated red blood cell; PICU = paediatric intensive care unit
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